F

Fresenius Medical Care

Operates dialysis facilities and renal care

Quality Assurance Specialist

Full-TimeUpdated on 10/23/2026Deadline 12/1/26
No salary listed
Mid
Bachelor's
Buzen, Fukuoka, Japan
In PersonOnsite at the Buzen plant; the role also supports quality operations at Inukai Plant.
Biology & BiotechRegulatory & Quality (Life Sciences)

About the job

Requirements
  • Communicate in Japanese at a native level.
  • Hold a bachelor's degree and have solid proficiency in Microsoft Word and Excel.
  • Have a good understanding of pharmaceutical Good Manufacturing Practice (GMP) and medical device Quality Management System requirements under ISO 13485.
  • Have practical knowledge and experience in quality assurance and document control within GMP/Quality Management System environments.
  • Communicate in English at a business-basic level.
Responsibilities
  • Execute and support GMP- and ISO 13485-based Quality Management System activities at Buzen Plant, including change control, deviations, nonconformance and corrective and preventive action (CAPA), and internal audits.
  • Lead data integrity programs, including compliance monitoring, improvement planning, and staff training.
  • Support regulatory authority audits and manage assigned follow-up tasks.
  • Perform supplier quality management, including supplier registration, change management, supplier audit program planning and monitoring, and key performance indicator reporting.
  • Create, revise, and manage GMP/Quality Management System documents.
  • Maintain the QDOK document management system and provide user training and support.
  • Prepare batch records and manage quality records and validation documentation.
  • Collect certificates of analysis for raw materials and support incoming material operations.
  • Enter raw material and finished product data into SAP.
  • Conduct visual inspections of packaging materials.
  • Perform other assigned quality assurance tasks as needed.
  • Communicate and collaborate with stakeholders across departments and sites to execute quality assurance and document-control activities.
  • Execute and support Quality Management System activities at Inukai Plant, including change control, deviation handling, nonconformance and CAPA, and internal audits.
  • Support regulatory authority audits at Inukai Plant and handle assigned tasks.
  • Perform supplier quality management at Inukai Plant, including supplier registration and change management, planning and monitoring supplier audit programs, and managing and reporting the key performance indicator program.
  • Create and revise Quality Management System documents at Inukai Plant.
  • Maintain the QDOK document management system and provide education and support to end users.
  • Manage quality records and validation reports at Inukai Plant.
  • Perform other assigned quality assurance-related tasks at Inukai Plant.
  • Communicate and collaborate with stakeholders in the department and across sites to execute the listed responsibilities.
  • Fulfill assigned authorities as Document Control Responsible, Internal Auditor, and Supplier Auditor.

About the company

F

Fresenius Medical Care

View

Fresenius Medical Care North America runs a network of dialysis facilities and outpatient labs to deliver coordinated kidney care for hundreds of thousands of patients. It also offers specialty pharmacy and laboratory services and manufactures a wide range of dialysis equipment, disposables, and renal drugs. The company treats patients by providing dialysis and related care at its clinics, supported by the equipment, supplies, and medicines it develops and distributes. FMCNA differentiates itself through its size and integration as the world's largest fully integrated renal company, with a nationwide network covering care delivery, drugs, labs, and manufacturing, aiming to provide high-quality, convenient access to comprehensive services across North America.

Company Size

11-50

Company Stage

Late Stage VC

Total Funding

$40.2M

Headquarters

Waltham, Massachusetts

Founded

1996

Get referred to Fresenius Medical Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 operating income rose 23%, showing transformation gains reached profitability.
  • FME25+ delivered EUR 67 million savings in Q2 2026 and targets EUR 1.2 billion.
  • Real-world evidence studies in July and August 2026 strengthen high-volume hemodiafiltration adoption.

What critics are saying

  • The August 2026 outlook disappointed investors after dialysis growth stalled and shares fell 10%.
  • FME25+ closed around 100 U.S. clinics in 2026, risking patient leakage to DaVita.
  • AB 290 litigation and premium-assistance rules threaten U.S. reimbursement economics and legal spend.

What makes Fresenius Medical Care unique

  • Fresenius Medical Care controls dialysis care, equipment, labs, and specialty pharmacy end-to-end.
  • Its 5008X CAREsystem reached around 100 clinics and 100,000 treatments by May 2026.
  • kinexus and TherapyWise deepen its software moat across home dialysis and kidney therapy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget
  • Conference Attendance Budget
  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
Business Wire
Mar 28th, 2024
Compsych Corporation Announces 2023 Health At Work Award Winners

CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Dec 6th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Home Health Provider
Feb 17th, 2023
Improving Access & Timely Care For Vulnerable Patients Referred To Home Health Via Telehealth Physician Support

Royal Philips (NYSE: PHG AEX: PHIA), a global leader in health technology, today announced the debut of its eCareManager 4.1 enterprise telehealth software at the American Telemedicine...